Peter Paul Platenburg
Business Developer
LiteVax BV
Ophemert, Gelderland, Netherlands
6 profile visits
LITEVAX is a biopharmaceutical company focussing on vaccine development using innovative vaccine adjuvant concepts to improve vaccines.
My organisation
LiteVax BV is a biopharmaceutical company focusing on the development and exploitation of novel human vaccine adjuvant products. Our lead adjuvant candidate outperforms commercially available alternatives with a higher efficacy without overt toxicity, allowing vaccine production at much lower costs and efficacy of one-shot applications. We are in the clinical stage of development with a second clinical trial started in February 2024 focusing on an improved influenza vaccine for the older population.
About me
My organisation
LiteVax BV
Additional questions
How would you categorise yourself?
Vaccine manufacturer
Organisation Type
Biotech company/R&DVaccine/Immunotherapy Manufacturer
Areas of expertise
Preclinical research Vaccine development Vaccine delivery systems Clinical development and trials
Therapeutic areas
Infectious diseases